SILAC-Based Quantitative Proteomic Analysis of Drosophila Embryos
- PMID: 36370280
- DOI: 10.1007/978-1-0716-2863-8_15
SILAC-Based Quantitative Proteomic Analysis of Drosophila Embryos
Abstract
The fruit fly Drosophila melanogaster represents a classic genetic model organism that is amenable to a plethora of comprehensive analyses including proteomics. SILAC-based quantitative proteomics is a powerful method to investigate the translational and posttranslational regulation ongoing in cells, tissues, organs, and whole organisms. Here we describe a protocol for routine SILAC labeling of Drosophila adults within one generation to produce embryos with a labeling efficiency of over 92%. In combination with genetic selection markers, this method permits the quantification of translational and posttranslational changes in embryos mutant for developmental and disease-related genes.
Keywords: Development; Drosophila; Embryo; Posttranslational modification; Proteomics; SILAC.
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Gonzalez C (2013) Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics. Nat Rev Cancer 13:172–183. https://doi.org/10.1038/nrc3461 - DOI - PubMed
-
- Harnish JM, Link N, Yamamoto S (2021) Drosophila as a model for infectious diseases. Int J Mol Sci 22. https://doi.org/10.3390/ijms22052724
-
- Oriel C, Lasko P (2018) Recent developments in using Drosophila as a model for human genetic disease. Int J Mol Sci 19. https://doi.org/10.3390/ijms19072041
-
- Ugur B, Chen K, Bellen HJ (2016) Drosophila tools and assays for the study of human diseases. Dis Model Mech 9:235–244. https://doi.org/10.1242/dmm.023762 - DOI - PubMed - PMC
-
- McGurk L, Berson A, Bonini NM (2015) Drosophila as an in vivo model for human neurodegenerative disease. Genetics 201:377–402. https://doi.org/10.1534/genetics.115.179457 - DOI - PubMed - PMC